HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 20, Issue 7, Pages 867-873
Publisher
Springer Nature
Online
2014-07-16
DOI
10.1038/mp.2014.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism
- (2013) Chi-Yi Yu et al. HUMAN MOLECULAR GENETICS
- The Aging Brain and Cognition
- (2013) Natalie L. Marchant et al. JAMA Neurology
- Statins, Risk of Dementia, and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study
- (2011) Kerstin Bettermann et al. Journal of Stroke & Cerebrovascular Diseases
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Proposed mechanism for lipoprotein remodelling in the brain
- (2010) Chunjiang Yu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cholesterol-related genes in Alzheimer's disease
- (2010) M. Axel Wollmer BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations
- (2010) Lina Keller et al. BRAIN RESEARCH
- Current status on Alzheimer disease molecular genetics: from past, to present, to future
- (2010) K. Bettens et al. HUMAN MOLECULAR GENETICS
- Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort
- (2010) Li Shen et al. NEUROIMAGE
- Clinical trial efforts in Alzheimer disease: Why test statins?
- (2010) Z. Arvanitakis et al. NEUROLOGY
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
- (2010) Minerva M. Carrasquillo et al. PLoS One
- Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk
- (2009) Eloy Rodríguez-Rodríguez et al. BRAIN RESEARCH
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13
- (2008) Ralph Burkhardt et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin
- (2008) Marisa Wong Medina et al. CIRCULATION
- Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
- (2008) M D M Haag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
- (2008) Raj N Kalaria et al. LANCET NEUROLOGY
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
- (2008) Yurii S Aulchenko et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now